~~<i id='1CC2154AE8'><strike id='1CC2154AE8'><tt id='1CC2154AE8'><pre id='1CC2154AE8'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

hotspot

author：fashion 2025-09-28 02:47:27 - browse：9233

JUUL store sign -- health coverage from STAT — Stephanie Keith/Getty Images

Documents released this week shed new light on an aggressive strategy from vape maker Juul to court Black leaders, including the Rev. Al Sharpton, to publicly support its e-cigarettes.

Beginning in 2018, Juul executives, including the company’s CEO, discussed six- and seven-figure partnerships with civil rights organizations, one of which would have seen it send as much as $7 million to Sharpton’s group, according to internal emails and documents that were released this week as part of a legal settlement with the state of North Carolina.

It’s not clear how much the company ultimately spent on the partnerships.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Moderna says combo Covid

hotspot

leisure time

focus

explore

hotspot

BRENDANSMIALOWSKI/AFPviaGettyImagesAthirdhumancaseofH5birdflutiedtotheongoingU.S.outbreakincattlehas

WSS

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

Statins may not be needed by millions of people, study suggests

Startling documents reveal new facets of Sacklers' opioid empire

Statins may not be needed by millions of people, study suggests

Adam's Biotech Scorecard: Do Sarepta's exon

Teladoc has a new CEO, but challenges remain the same

explore

hotspot

hotspot

George Santos makes 1st court appearance after pleading not guilty to 13 counts

iTeos Therapeutics debuts first data on TIGIT

Heart attack and stroke risk calculators need revising

Curing rare childhood diseases will falter unless Congress steps up

Trump demands the U.S. pay no more for drugs than other countries … again

The system is set up to fail children with medical complexity

Virginia high school admissions case could be legal follow

Antibiotic resistance nearly killed me, so I'm raising awareness of it

Alkermes shareholders re

Medical device trials still don't enroll enough women, study finds

leisure time

How faith leaders like me can help address America's obesity epidemic

NIH tests clinical research in primary care with $30 million program

How the BIOSECURE Act is already affecting U.S., Chinese life science firms

Teladoc has a new CEO, but challenges remain the same

Gene therapies for deafness raise the question: Do deaf people want a 'cure'?

STAT Virtual Event: ASCO Recap, Live!

focus

explore

hotspot

hotspot